Akshay Bansal Appointed Executive Director at Ennature Bio Pharma Limited
India Glycols Limited announced that Shri Akshay Bansal, formerly the Head of Sales & Marketing for its Ennature Biopharma Division, has been appointed as an Additional Director (Executive Director) and Key Managerial Personnel (KMP) of Ennature Bio Pharma Limited (EBL). This appointment was approved by the Board of Directors of EBL and is effective from July 31, 2026.The transition details indicate that Shri Bansal transferred to the wholly owned subsidiary, Ennature Bio Pharma Limited, ceasing his role as a Senior Managerial Personnel (SMP) at India Glycols Limited from the close of business hours on July 30, 2026.
Ennature Bio Pharma Limited, in connection with its business operations and Scheme of Arrangement, appointed Shri Bansal to the leadership role. His appointment is set for a term of five consecutive years, running until July 30, 2031.
Shri Akshay Bansal, who holds DIN: 11836049, brings significant experience to his new position. He possesses 26 years of professional experience across the pharmaceuticals, nutraceuticals, and nicotine industries. His expertise spans manufacturing operations, international commercial strategy, supply chain management, and business development.
Details regarding Shri Bansal's background are as follows:
| Particular | Details |
|---|---|
| Age | 52 years |
| Experience | 26 years across pharmaceuticals, nutraceuticals, and nicotine industries |
| Education | Graduate degree in Hospital Administration; Master’s degree in Business Administration (MBA) from Devi Ahilya University, Indore. Completed Certificate Programme in General Management (CPGM) from the Institute of Management Studies, Lucknow. |
| Prior Role | Head Sales & Marketing for Ennature Bio Pharma Division at India Glycols Limited. |
| Previous Employers | Mankind Pharma Ltd., Glenmark Generics Ltd., Dishman Group, Alembic Pharmaceuticals Ltd., and Orchid Pharma. |
INDIAGLYCO Stock Price Movement
Today, shares of India Glycols Limited edged higher to close at ₹1147.45, recording a gain of 1.57%. The stock traded within an intraday range spanning from a low of ₹1121.15 to a high of ₹1160.90 during trading today.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.